The disadvantageous risk factor profile in relation to the no-NAFLD group was observed also when considering the baseline blood pressure, markers of lipid and glucose metabolism, as well as liver enzyme and C-reactive protein concentrations of the incident group. The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.